Company profile

U3 Pharma company profile

U3 Pharma GmbH, based in Martinsried near Munich, Germany, is a leader in targeted cancer drug development. Established in July 2001, the company has produced a pipeline of novel targeted therapeutics based on the ground-breaking discoveries made by its founder - Professor Axel Ullrich. Since May 2008 U3 Pharma belongs to DAIICHI Sankyo Co. Ltd., one of the top 20 leading pharmaceutical companies worldwide and no. 3 in Japan. Being part of this global environment, U3 Pharma is striving to provide patients around the world with innovative antibody-based therapeutics.

Business identity

Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Founded
2001-01-01

Headquarters

Headquarters
Bayern, Germany, Planegg
Postal code
82152
Country code
DE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
2
Total equity funding
$50.8M
Last funding
Series Unknown / $34M / 2006-05-22
Last equity funding
Series Unknown / $34M
Investors
7
Lead investors
3
Founders
2
Exited on
2008-05-21

Founders and investors

Founders

Edward StuartTom Geimer

Lead investors

Atlas VentureLCF RothschildLSP BioVentures

Investors

Alta PartnersAtlas VentureBio*One CapitalEdmond de Rothschild Private EquityLSP BioVentures

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.